Scorpius Holdings Announces Reverse Stock Split

Company Overview - Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) focused on advancing biologic and cell therapy programs [2] - The company provides a wide range of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas [2] Reverse Stock Split Announcement - At the Annual Meeting held on July 15, 2024, stockholders approved a reverse stock split of the company's Common Stock at a ratio of 1-for-200 [1] - The reverse stock split aims to increase the selling price of the Common Stock to regain compliance with NYSE American requirements [6] - The reverse stock split will take legal effect at 11:01 P.M. Eastern Time on July 17, 2024, with trading on a post-split basis commencing on July 18, 2024 [3][6] Compliance and Future Outlook - The company is seeking to regain compliance with NYSE American requirements through the reverse stock split, although there is no assurance that this will be successful [6] - The ownership percentage of each stockholder will remain unchanged, except for fractional shares [1]